Embryonic stem cell (ES cell)-derived cardiomyocyte transplantation into the infarcted myocardium

将胚胎干细胞(ES细胞)来源的心肌细胞移植到梗塞心肌中

基本信息

  • 批准号:
    13671401
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

The purpose of this study was to investigate the survival of embryonic stem cell (ES cell)-derived cardiomyocytes transplanted into the infarcted myocardium.In in vitro study, undifferentiated mouse ES cells carrying the enhanced green fluorescent protein (EGFP) were cultured in hanging drops for 7 days and plated onto dishes, and then beating clusters were dissected and used for the following analyses and transplantation. These cells were identified as cardiomyocytes by reverse transcription-polymerase chain reaction of cardiac-specific genes, recording of action potential, and immunostaining of sarcomeric myosin staining. As a result of in vitro study, ES cell-derived cardiomyocytes were shown to have myosin light chain-2v and alpha-myosin heavy chain genes expression, action potential like one from a sinus nodal cell and a ventricular myocyte, and positive for sarcomeric myosin staining.In in vivo study, a myocardial infarction rat model was made by the ligation of the left coronary artery. Beating clusters were injected into the border zone between the infarcted and normal myocardium. Ten and 30 days after transplantation EGFP expression, hematoxylin-eosin staining and immunostaining of sarcomeric myosin were investigated. As a result of in vivo study, EGFP-expressed cells were detected after transplantation, and a few of them were positive for sarcomeric myosin. No lymphocytic infiltration was observed.These results suggested that ES cells differentiated into cardiomyocytes in vitro and ES cell-derived cardiomyocytes could be transplanted into the infarcted myocardium and survive in vivo.
本研究的目的是研究胚胎干细胞(ES细胞)来源的心肌细胞移植到梗塞心肌后的存活情况。在体外研究中,携带增强型绿色荧光蛋白(EGFP)的未分化小鼠ES细胞在悬滴中培养7天并铺在培养皿上,然后解剖打浆簇并用于以下分析和移植。通过心脏特异性基因的逆转录聚合酶链反应、记录动作电位以及肌节肌球蛋白染色的免疫染色,将这些细胞鉴定为心肌细胞。体外研究结果显示,ES细胞来源的心肌细胞具有肌球蛋白轻链2v和α-肌球蛋白重链基因表达,具有与窦房结细胞和心室肌细胞类似的动作电位,并且肌球蛋白呈阳性染色。在体内研究中,通过结扎左冠状动脉制作心肌梗死大鼠模型。将跳动簇注入梗塞心肌和正常心肌之间的边界区域。移植后10天和30天,研究了EGFP表达、苏木精-伊红染色和肌节肌球蛋白的免疫染色。体内研究结果显示,移植后检测到表达EGFP的细胞,其中少数细胞肌节肌球蛋白呈阳性。没有观察到淋巴细胞浸润。这些结果表明ES细胞在体外分化为心肌细胞,并且ES细胞衍生的心肌细胞可以移植到梗塞心肌并在体内存活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANIGUCHI Shigeki其他文献

TANIGUCHI Shigeki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANIGUCHI Shigeki', 18)}}的其他基金

Hydrogen sulfide protects insulin-secreting cells from cell damage-Characterization of the cytoprotective effects and the molecular mechanisms-
硫化氢保护胰岛素分泌细胞免受细胞损伤-细胞保护作用和分子机制的表征-
  • 批准号:
    22790255
  • 财政年份:
    2010
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Construction of 3D cardiac tissue: alignment and maturation of cells, and improvement of contraction force by extensional stimulation
3D 心脏组织的构建:细胞的排列和成熟,以及通过拉伸刺激改善收缩力
  • 批准号:
    22591552
  • 财政年份:
    2010
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New therapy for heart failure: Engineered heart tissue toward to clinical use
心力衰竭的新疗法:工程心脏组织走向临床应用
  • 批准号:
    19591642
  • 财政年份:
    2007
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The studies of the functional significance of regenerating gene (Reg) in failing hearts.
再生基因(Reg)在衰竭心脏中的功能意义的研究。
  • 批准号:
    16591405
  • 财政年份:
    2004
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Xenotransplantation of ex vivo gene trandected cardiomyocytes
离体基因转染心肌细胞的异种移植
  • 批准号:
    11470277
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Attempt at creating donor pig by nuclear transplantation for xenotrasplantation
异种移植用核移植培育供体猪的尝试
  • 批准号:
    09671389
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

预移植过表达HLA-G基因的间充质基质细胞提高心肌内移植的异体心肌细胞存活率的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SENP1介导Nrf2去SUMO化调节心肌细胞铁死亡在移植心脏缺血再灌注损伤中的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
纳米微粒缓释FasL蛋白增强人多能干细胞衍生心室型心肌细胞移植治疗猪心梗的疗效和机制研究
  • 批准号:
    82270261
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
STRA13介导的心肌细胞铁死亡在移植供心缺血再灌注损伤中的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
免疫兼容型人多能干细胞源心肌细胞移植治疗心肌梗死的研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Identification of Novel Transcriptional Regulators of Stem Cell Derived Cardiomyocyte Maturation
干细胞来源的心肌细胞成熟的新型转录调节因子的鉴定
  • 批准号:
    9906423
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
Identification of Novel Transcriptional Regulators of Stem Cell Derived Cardiomyocyte Maturation
干细胞来源的心肌细胞成熟的新型转录调节因子的鉴定
  • 批准号:
    10321528
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
Integration and Arrhythmia Suppression with hESC-Derived Cardiomyocyte Grafts
hESC 来源的心肌细胞移植物的整合和心律失常抑制
  • 批准号:
    8701393
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
Integration and Arrhythmia Suppression with hESC-Derived Cardiomyocyte Grafts
hESC 来源的心肌细胞移植物的整合和心律失常抑制
  • 批准号:
    8477849
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
Scalable bioprocess for cardiomyocyte generation from human embryonic stem cells
从人类胚胎干细胞生成心肌细胞的可扩展生物过程
  • 批准号:
    7844222
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了